rethinkTHC Search
Menu
Study breakdown

Medical Cannabis Did Not Significantly Improve Pain, Nausea, or Sleep Scores in Elderly Cancer Patients

Retrospective CohortPreliminary evidence
The takeaway

A retrospective review of elderly cancer patients found no statistically significant change in pain, nausea, appetite, insomnia, or anxiety scores after starting medical cannabis, though oil and high-THC products were most commonly used.

Elderly cancer patients considering medical cannabis, oncologists, palliative care providers.

No significant symptom improvement in any of 5 domains measured

What the researchers found

There was no statistically significant difference in symptom scores for pain, nausea, appetite, insomnia, or anxiety before versus after medical cannabis initiation. Oil was the most common form used, followed by vape. The most common product ratios were high THC:CBD and equal parts THC:CBD.

Why it matters

Despite growing use of medical cannabis for cancer symptom management, evidence in elderly patients specifically remains limited. This null result is important because it tempers expectations while also highlighting the need for larger, prospective studies in this vulnerable population.

The numbers in context

No statistically significant changes in any of five symptom domains measured. Oil most common form, followed by vape. High THC:CBD and equal THC:CBD ratios most commonly used.

How the study worked

Retrospective chart review assessing changes in numerical symptom scores reported at clinic visits before and after medical cannabis initiation in elderly cancer patients.

What this study cannot tell us

Retrospective chart review with likely small sample size and inconsistent follow-up. No control group. Self-reported symptom scores. Variable products, doses, and duration of use. Selection bias in who gets prescribed medical cannabis.

How to read the evidence

Retrospective chart review without a control group, with likely small sample and variable treatment protocols.

When this study was published

Published 2023.

The bigger picture

The null result could reflect true lack of efficacy, or it could be an artifact of the retrospective design, small sample, inconsistent dosing, or the fact that elderly cancer patients often have severe symptoms resistant to many treatments. The study does confirm that elderly patients are commonly choosing THC-containing products.

Questions still open

  • Would a prospective trial with standardized dosing show different results in elderly cancer patients?
  • Are there specific cancer symptom subgroups where medical cannabis is more effective in elderly patients?

Common questions

Does medical cannabis help with cancer symptoms in elderly patients?
This retrospective study found no significant improvement in pain, nausea, appetite, insomnia, or anxiety after starting medical cannabis, though study limitations may have obscured real effects.
What forms of cannabis did elderly cancer patients prefer?
Oil was the most common form, followed by vape. Patients most often chose high-THC or equal THC:CBD ratio products.

Read the original research

Assessing Efficacy and Use Patterns of Medical Cannabis for Symptom Management in Elderly Cancer Patients.

The American journal of hospice & palliative care, 40(4), 368-373

Citation

Nathan, Rachel; Mupamombe, Charles T; Elibol, John; Case, Amy A; Smith, Danielle; Hyland, Andrew; Attwood, Kristopher; Hansen, Eric D. (2023). Assessing Efficacy and Use Patterns of Medical Cannabis for Symptom Management in Elderly Cancer Patients.. The American journal of hospice & palliative care, 40(4), 368-373. https://doi.org/10.1177/10499091221110217

Explore the wider topic